sodium methotrexate

Poland

Drugs containing this active substance

  • EBETREXAT

    The medicine is used in the treatment of adults with active rheumatoid arthritis and in individuals with severe, treatment-resistant psoriasis or psoriatic arthritis. It is also used in children and adolescents with polyarticular forms of severe juvenile idiopathic arthritis, if other anti-inflammatory drugs have not helped.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    sodium methotrexate 21.94 mg/ml

    ATC: L04AX03

    Manufacturer: Ebewe Pharma Ges.m.b.H Nfg. KG Fareva Unterach GmbH Salutas Pharma GmbH

  • METEX

    The drug is used for the treatment of, among others, active rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis, severe psoriasis, psoriatic arthritis, and Crohn's disease.

    Form: solution for injection

    Active substance Dosage
    sodium methotrexate 54.84 mg

    ATC: L04AX03

    Manufacturer: medac GmbH

  • METEX PEN

    The medicinal product is used in the treatment of active rheumatoid arthritis in adults and the polyarticular form of severe juvenile idiopathic arthritis. It is also used in cases of moderate to severe psoriasis, severe psoriatic arthritis, and mild to moderate Crohn's disease.

    Form: solution for injection in a syringe

    Active substance Dosage
    sodium methotrexate 7.5 mg

    ATC: L01BA01

    Manufacturer: medac GmbH for Clinical Special Preparations

  • METEX PEN

    The medicine is used to treat active rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis, moderate to severe psoriasis, psoriatic arthritis, and Crohn's disease (mild to moderate).

    Form: solution for injection in a syringe

    Active substance Dosage
    sodium methotrexate 12.5 mg

    ATC: L01BA01

    Manufacturer: medac GmbH for Clinical Special Preparations

  • METEX PEN

    The medicine is used for the treatment of active rheumatoid arthritis in adults, polyarticular severe juvenile idiopathic arthritis, moderate and severe psoriasis, and severe psoriatic arthritis in adults, as well as mild to moderate Crohn's disease.

    Form: solution for injection in a syringe

    Active substance Dosage
    sodium methotrexate 10 mg

    ATC: L01BA01

    Manufacturer: medac GmbH for Clinical Special Preparations

  • METEX PEN

    The medicine is used in the treatment of active rheumatoid arthritis in adults, the polyarticular form of severe juvenile idiopathic arthritis, moderate and severe psoriasis, psoriatic arthritis, and mild to moderate Crohn's disease.

    Form: solution for injection in a syringe

    Active substance Dosage
    sodium methotrexate 15 mg

    ATC: L01BA01

    Manufacturer: medac GmbH for Clinical Special Preparations

  • METEX PEN

    The medicine is used for the treatment of rheumatoid arthritis in adults and the polyarticular form of severe juvenile idiopathic arthritis. It is also indicated for moderate and severe psoriasis, psoriatic arthritis in adults, and mild to moderate Crohn's disease.

    Form: solution for injection in a syringe

    Active substance Dosage
    sodium methotrexate 17.5 mg

    ATC: L01BA01

    Manufacturer: medac GmbH for Clinical Special Preparations

  • METEX PEN

    The medicine is used for the treatment of active rheumatoid arthritis in adults, the polyarticular form of severe juvenile idiopathic arthritis, moderate and severe psoriasis, and severe psoriatic arthritis in adults, as well as mild to moderate Crohn's disease in adult patients.

    Form: solution for injection in a syringe

    Active substance Dosage
    sodium methotrexate 20 mg

    ATC: L01BA01

    Manufacturer: medac GmbH for Clinical Special Preparations

  • METEX PEN

    The drug is used in the treatment of rheumatoid arthritis in adults and the polyarticular form of severe juvenile idiopathic arthritis. It is also indicated for moderate to severe psoriasis, psoriatic arthritis, and mild to moderate Crohn's disease.

    Form: solution for injection in a syringe

    Active substance Dosage
    sodium methotrexate 22.5 mg

    ATC: L01BA01

    Manufacturer: medac GmbH for Clinical Special Preparations

  • METEX PEN

    The medicine is used to treat active rheumatoid arthritis in adults and the polyarticular form of severe juvenile idiopathic arthritis. It is also intended for the treatment of moderate to severe psoriasis, psoriatic arthritis in adults, and mild to moderate Crohn's disease.

    Form: solution for injection in a syringe

    Active substance Dosage
    sodium methotrexate 25 mg

    ATC: L01BA01

    Manufacturer: medac GmbH for Clinical Special Preparations

  • METEX PEN

    The medicine is used for the treatment of active rheumatoid arthritis in adults and the polyarticular form of severe juvenile idiopathic arthritis. It is also used in cases of moderate to severe psoriasis, psoriatic arthritis in adults, and mild to moderate Crohn's disease.

    Form: solution for injection in a syringe

    Active substance Dosage
    sodium methotrexate 27.5 mg

    ATC: L01BA01

    Manufacturer: medac GmbH for Clinical Special Preparations

  • METEX PEN

    The medicine is used in the treatment of rheumatoid arthritis in adults and the polyarticular form of severe juvenile idiopathic arthritis. It is also indicated for moderate to severe psoriasis, psoriatic arthritis, and mild to moderate Crohn's disease.

    Form: solution for injection in a syringe

    Active substance Dosage
    sodium methotrexate 30 mg

    ATC: L01BA01

    Manufacturer: medac GmbH for Clinical Special Preparations